JP2013535986A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535986A5 JP2013535986A5 JP2013526153A JP2013526153A JP2013535986A5 JP 2013535986 A5 JP2013535986 A5 JP 2013535986A5 JP 2013526153 A JP2013526153 A JP 2013526153A JP 2013526153 A JP2013526153 A JP 2013526153A JP 2013535986 A5 JP2013535986 A5 JP 2013535986A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- labeled
- polymerase
- sequence
- sequencing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020004414 DNA Proteins 0.000 description 16
- 230000006820 DNA synthesis Effects 0.000 description 10
- 238000012544 monitoring process Methods 0.000 description 10
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 8
- 239000011324 bead Substances 0.000 description 7
- 102100034343 Integrase Human genes 0.000 description 6
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 230000011987 methylation Effects 0.000 description 5
- 238000007069 methylation reaction Methods 0.000 description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 3
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 3
- 238000002966 oligonucleotide array Methods 0.000 description 3
- 229940035893 uracil Drugs 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- HWPZZUQOWRWFDB-UHFFFAOYSA-N 1-methylcytosine Chemical compound CN1C=CC(N)=NC1=O HWPZZUQOWRWFDB-UHFFFAOYSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40235010P | 2010-08-27 | 2010-08-27 | |
| US61/402,350 | 2010-08-27 | ||
| PCT/US2011/049151 WO2012027572A2 (en) | 2010-08-27 | 2011-08-25 | Methods for nucleic acid capture and sequencing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535986A JP2013535986A (ja) | 2013-09-19 |
| JP2013535986A5 true JP2013535986A5 (OSRAM) | 2014-10-09 |
Family
ID=44545975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013526153A Pending JP2013535986A (ja) | 2010-08-27 | 2011-08-25 | 核酸の捕捉法および配列決定法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20130324419A1 (OSRAM) |
| EP (1) | EP2609214A2 (OSRAM) |
| JP (1) | JP2013535986A (OSRAM) |
| KR (1) | KR20130101031A (OSRAM) |
| CN (1) | CN103080338A (OSRAM) |
| BR (1) | BR112013002299A2 (OSRAM) |
| CA (1) | CA2803693A1 (OSRAM) |
| MX (1) | MX2013001799A (OSRAM) |
| RU (1) | RU2013113407A (OSRAM) |
| WO (1) | WO2012027572A2 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9074251B2 (en) | 2011-02-10 | 2015-07-07 | Illumina, Inc. | Linking sequence reads using paired code tags |
| WO2012106546A2 (en) | 2011-02-02 | 2012-08-09 | University Of Washington Through Its Center For Commercialization | Massively parallel continguity mapping |
| NO2694769T3 (OSRAM) | 2012-03-06 | 2018-03-03 | ||
| EP2875173B1 (en) * | 2012-07-17 | 2017-06-28 | Counsyl, Inc. | System and methods for detecting genetic variation |
| US9683230B2 (en) | 2013-01-09 | 2017-06-20 | Illumina Cambridge Limited | Sample preparation on a solid support |
| EP2970951B1 (en) | 2013-03-13 | 2019-02-20 | Illumina, Inc. | Methods for nucleic acid sequencing |
| AU2014364926B2 (en) | 2013-12-20 | 2017-12-14 | Illumina, Inc. | Preserving genomic connectivity information in fragmented genomic DNA samples |
| KR102472027B1 (ko) * | 2014-10-17 | 2022-11-30 | 일루미나 케임브리지 리미티드 | 근접 보존 전위 |
| PT3207134T (pt) * | 2014-10-17 | 2019-09-17 | Illumina Cambridge Ltd | Transposição que preserva a contiguidade |
| US9859394B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| US9618474B2 (en) | 2014-12-18 | 2017-04-11 | Edico Genome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| US9857328B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same |
| US10006910B2 (en) | 2014-12-18 | 2018-06-26 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same |
| EP3235010A4 (en) | 2014-12-18 | 2018-08-29 | Agilome, Inc. | Chemically-sensitive field effect transistor |
| US10020300B2 (en) | 2014-12-18 | 2018-07-10 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
| US10395759B2 (en) * | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
| WO2017201081A1 (en) | 2016-05-16 | 2017-11-23 | Agilome, Inc. | Graphene fet devices, systems, and methods of using the same for sequencing nucleic acids |
| EP3650553B1 (en) * | 2018-11-07 | 2023-07-12 | Siemens Healthcare GmbH | Method for detection of specific nucleic acids |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO165894C (no) * | 1988-05-24 | 1991-04-24 | Gunnar Paulsen | Analysemetode for gener. |
| US6982146B1 (en) * | 1999-08-30 | 2006-01-03 | The United States Of America As Represented By The Department Of Health And Human Services | High speed parallel molecular nucleic acid sequencing |
| WO2008115185A2 (en) | 2006-04-24 | 2008-09-25 | Nimblegen Systems, Inc. | Use of microarrays for genomic representation selection |
| WO2008096146A1 (en) * | 2007-02-07 | 2008-08-14 | Solexa Limited | Preparation of templates for methylation analysis |
| WO2008103848A1 (en) * | 2007-02-21 | 2008-08-28 | Invitrogen Corporation | Materials and methods for single molecule nucleic acid sequencing |
| WO2009024019A1 (en) * | 2007-08-15 | 2009-02-26 | The University Of Hong Kong | Methods and compositions for high-throughput bisulphite dna-sequencing and utilities |
| US20110281740A1 (en) | 2008-06-30 | 2011-11-17 | Joseph Beechem | Methods for Real Time Single Molecule Sequencing |
| US8795961B2 (en) * | 2008-09-05 | 2014-08-05 | Pacific Biosciences Of California, Inc. | Preparations, compositions, and methods for nucleic acid sequencing |
| WO2010085343A1 (en) | 2009-01-23 | 2010-07-29 | Cold Spring Harbor Laboratory | Methods and arrays for profiling dna methylation |
-
2011
- 2011-08-25 RU RU2013113407/10A patent/RU2013113407A/ru not_active Application Discontinuation
- 2011-08-25 MX MX2013001799A patent/MX2013001799A/es not_active Application Discontinuation
- 2011-08-25 BR BR112013002299A patent/BR112013002299A2/pt not_active IP Right Cessation
- 2011-08-25 EP EP11752056.9A patent/EP2609214A2/en not_active Withdrawn
- 2011-08-25 CA CA2803693A patent/CA2803693A1/en not_active Abandoned
- 2011-08-25 JP JP2013526153A patent/JP2013535986A/ja active Pending
- 2011-08-25 KR KR1020137007586A patent/KR20130101031A/ko not_active Withdrawn
- 2011-08-25 US US13/819,657 patent/US20130324419A1/en not_active Abandoned
- 2011-08-25 CN CN2011800416596A patent/CN103080338A/zh active Pending
- 2011-08-25 WO PCT/US2011/049151 patent/WO2012027572A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535986A5 (OSRAM) | ||
| NZ608313A (en) | Direct capture, amplification and sequencing of target dna using immobilized primers | |
| JP2014503207A5 (OSRAM) | ||
| WO2007118147A3 (en) | Competitive oligonucleotides | |
| CN107760772B (zh) | 用于核酸配对末端测序的方法、组合物、系统、仪器和试剂盒 | |
| RU2019138698A (ru) | Способы и композиции для днк-профилирования | |
| FI3564394T3 (fi) | Menetelmä alukkeen polynukleotidien kirjastojen valmistamiseksi | |
| JP6899844B2 (ja) | 超並列シークエンシングのためのｄｎａライブラリーを生成する方法及びキット | |
| JP2014504153A5 (OSRAM) | ||
| CA2892646A1 (en) | Methods for targeted genomic analysis | |
| JP2008535489A5 (OSRAM) | ||
| WO2007130519A3 (en) | Viral nucleic acid microarray and method of use | |
| JP2012514451A5 (OSRAM) | ||
| WO2010117817A2 (en) | Methods for generating target specific probes for solution based capture | |
| JP2008535509A5 (OSRAM) | ||
| JP2015156872A5 (OSRAM) | ||
| JP2013535986A (ja) | 核酸の捕捉法および配列決定法 | |
| JP2018518967A5 (OSRAM) | ||
| JP2010539920A5 (OSRAM) | ||
| WO2011135280A3 (en) | Enzymes | |
| JP2017537658A5 (OSRAM) | ||
| JP2011101652A5 (OSRAM) | ||
| JP2017514478A5 (OSRAM) | ||
| WO2014118377A3 (en) | Primer technology | |
| WO2009101193A1 (en) | Microarray for the analysis of nucleotide sequences |